An elongated medical tubular assembly is configured to improve, at least in part, transmission of a signal from the signal-transmitting device, received, at least in part, within the elongated medical tubular assembly, toward the signal-transceiving device of the medical-imaging system. The elongated medical tubular assembly defines a lumen extending from a distal tip toward a proximal end of the elongated medical tubular assembly; and the lumen is configured to receive, at least in part, the signal-transmitting device in such a way that the lumen, in use, receives, at least in part, the signal-transmitting device at the signal-liberating feature.

Disclosed are methods and systems for restoring patency across a vascular or non-vascular occlusion. The system may include a retrograde catheter, having a proximal end, a distal end, a first central lumen and a first side port spaced proximally apart from the distal end, the first central lumen extending at least as far as the first side port. An antegrade catheter is also provided, having a proximal end, a distal end, a second central lumen in communication with a second side port spaced proximally apart from the distal end. The catheters may have complementary surface configurations to facilitate alignment of the first and second side ports, so that a wire may be passed out of one of the side ports and into the other side port.

Disclosed are methods and devices for restoring patency across a vascular or non-vascular occlusion. A first catheter having a first side port is configured to advance in a first direction through a vessel from a vascular access site on a first side of the occlusion. A second catheter having a second side port is configured to advance in a second direction through the vessel from a vascular access site on a second side of the occlusion. The catheters may have complementary surface configurations to facilitate alignment of the first and second side ports, so that a wire may be passed through the catheters, out of one of the side ports and into the other side port, to bypass the occlusion.

An implantable device has a body that is substantially rigid and has a predetermined shape. The body is further bioabsorbable and has a density less than or equal to about 1.03 g/cc. When the device is implanted in a resected cavity in soft tissue, it causes the cavity to conform to the predetermined shape. The implantable device is further imageable due to its density being less than that of soft tissue such that the boundaries of the tissue corresponding to the predetermined shape can be determined.

Disclosed are systems, devices, and methods for planning a procedure for treatment of tissue in a patient's lungs. An exemplary method includes generating a three-dimensional (3D) model of the patient's lungs, displaying the 3D model of the patient's lungs, selecting a target location in the tissue of the patient's lungs as displayed on the 3D model, identifying a point on a pleural surface of the patient's lungs with access to the target location, determining an access path between the target location and the identified point on the pleural surface, calculating a risk of injury to intervening structures between the identified point on the pleural surface and the target location, based on the determined access path, and displaying the access path and the calculated risk of injury for the access path on the 3D model.

The disclosure provides various embodiments of systems to facilitate the cutting of luminal tissue structures percutaneously.

Apparatus, systems, and methods are provided for localizing lesions within a patient's body, e.g., within a breast. The system may include one or more markers implantable within or around the target tissue region, and a probe for transmitting and receiving electromagnetic signals to detect the one or more markers. During use, the marker(s) are into a target tissue region, and the probe is placed against the patient's skin to detect and localize the marker(s). A tissue specimen, including the lesion and the marker(s), is then removed from the target tissue region based at least in part on the localization information from the probe.

In some embodiments, a method includes identifying a nerve extending across a transection path; administering a cooling therapy to the identified nerve at a location proximal to the transection path so as to degenerate the identified nerve across the transection path prior to or during surgical transection along the transection path, wherein cooling the identified nerve prevents or reduces neuroma formation at a transected end of the nerve after transection of the nerve. In some embodiments, a method includes degenerating a portion of a nerve while preserving a connective tissue framework of the nerve. During or after the degeneration, the preserved connective tissue framework may be transected at a transection location distal to the treatment location. The regeneration of the nerve may be repeatedly disrupted for a period of time to reduce a regenerative rate of the nerve and delay neuroma formation.

Provided in accordance with the present disclosure are systems and methods for identifying a percutaneous tool in image data. An exemplary method includes receiving image data of at least a portion of a patient's body, identifying an entry point of a percutaneous tool through the patient's skin in the image data, analyzing a portion of the image data including the entry point of the percutaneous tool through that patient's skin to identify a portion of the percutaneous tool inserted through the patient's skin, determining a trajectory of the percutaneous tool based on the identified portion of the percutaneous tool inserted through the patient's skin, identifying a remaining portion of the percutaneous tool in the image data based on the identified entry point and the determined trajectory of the percutaneous tool, and displaying the identified portions of the percutaneous tool on the image data.

An AR headset is described to co-localize an image data set with a body of a person. One method can include identifying optical codes with a contrast medium in a tubing on the body of the person using the AR headset. The image data set can be aligned with the body of the person using the fixed position of the image visible marker with the contrast medium in the tubing with respect to the optical code referenced to a representation of the image visible marker. In one configuration, an image data set can be scaled by comparing a measured size of the image visible marker (e.g., gadolinium tubing) in the captured image data set to the known size of the image visible marker. In addition, a center of an optical code may be identified to more accurately align the image data set with a body of a person.